TABLE 2.
Comparative yields of clinically significant isolates in PFA versus FA aerobic blood culture bottles from patients receiving antimicrobial therapy
| Microorganism(s) | No. of isolates recovered from:
|
Pa | ||
|---|---|---|---|---|
| Both bottles | PFA bottles only | FA bottles only | ||
| Staphylococcus aureus | 14 | 3 | 3 | NS |
| Coagulase-negative staphylococci | 9 | 2 | 1 | NS |
| Enterococcus sp. | 5 | 0 | 1 | NS |
| Corynebacterium jekeium | 1 | 0 | 1 | NS |
| Enterobacteriaceaeb | 11 | 3 | 4 | NS |
| Other gram-negative bacteriac | 9 | 1 | 3 | NS |
| Yeastsd | 16 | 7 | 5 | NS |
| All microorganisms | 65 | 16 | 18 | NS |
NS, not significant.
Includes E. coli (eight isolates), K. pneumoniae (four isolates), Enterobacter aerogenes (three isolates), Enterobacter cloacae (two isolates), and Proteus mirabilis (one isolate).
Includes P. aeruginosa (four isolates), Stenotrophomonas maltophilia (three isolates), B. cepacia (three isolates), Acinetobacter sp. (one isolate), O. anthropi (one isolate), and an unidentified gram-negative rod (one isolate).
Includes Candida albicans (10 isolates), Candida krusei (9 isolates), Candida parapsilosis (6 isolates), Cryptococcus neoformans (2 isolates), and Candida lusitaniae (1 isolate).